UK:
Is The Price Right? A Survey On Benchmark Pricing By Clyde & Co In Association With Commodities Now
29 January 2015
Clyde & Co
To print this article, all you need is to be registered or login on Mondaq.com.
Two thirds believe benchmarks open to
manipulation.
A credible system for agreeing benchmark pricing is fundamental
to the proper functioning of markets and the avoidance of price
manipulation. Although the current system is not broken, there is
broad industry consensus that it can be improved, according to the
results of research just published by Clyde & Co. 170
respondents from across the commodities sector responded to a Clyde
& Co survey conducted in conjunction with industry magazine
Commodities Now during October and November 2014. Only one fifth
felt benchmark prices were "entirely fit for purpose".
Less than two thirds were "somewhat satisfied" that the
current system of benchmark pricing works "adequately
well" and 15% believed benchmarks were "substantially
flawed." (click here to view the full report)
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Finance and Banking from UK
Asset Recovery Comparative Guide
Bird & Bird
Asset Recovery Comparative Guide for the jurisdiction of UK, check out our comparative guides section to compare across multiple countries
FCA's Consultation Paper
Cadwalader, Wickersham & Taft LLP
Since 3 January 2018, firms that provide portfolio management or investment advice on an independent basis must pay for the research they obtain...
Regulation Round Up
Proskauer Rose LLP
Welcome to the UK Regulation Round Up, a regular bulletin highlighting the latest developments in UK and EU financial services regulation.
FCA To Permit Research Bundling
Akin Gump Strauss Hauer & Feld LLP
The Financial Conduct Authority (FCA) is seeking views on proposed rules that would allow asset managers to opt for bundled payments for third-party investment research, reversing a significant aspect of the UK's implementation of research rules under the Markets in Financial Instruments Directive (MiFID II).